{"result": {"id": "cc52bf91-74d8-42cb-a481-cc586648ee04", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>沙库巴曲缬沙坦<|>organization<|>沙库巴曲缬沙坦是一种药物，用于治疗高血压和心力衰竭，可额外降低诊室收缩压和动态血压，并在特殊人群中显示出降压优势\")  \n##  \n(\"entity\"<|>ARNI<|>organization<|>ARNI（血管紧张素受体脑啡肽酶抑制剂）是一类药物，包括沙库巴曲缬沙坦，用于高血压和心力衰竭治疗，需注意与其他药物的联用禁忌\")  \n##  \n(\"entity\"<|>奥美沙坦<|>organization<|>奥美沙坦是一种ARB类药物，用于治疗高血压，与沙库巴曲阿利沙坦相比降压效果较弱\")  \n##  \n(\"entity\"<|>沙库巴曲阿利沙坦<|>organization<|>沙库巴曲阿利沙坦是一种新型降压药，在Ⅲ期临床试验中显示出比奥美沙坦更强的降压效果和良好的耐受性\")  \n##  \n(\"relationship\"<|>沙库巴曲缬沙坦<|>ARNI<|>沙库巴曲缬沙坦属于ARNI类药物，具有相似的药理作用和临床应用<|>8\")  \n##  \n(\"relationship\"<|>沙库巴曲阿利沙坦<|>奥美沙坦<|>沙库巴曲阿利沙坦在临床试验中显示出比奥美沙坦更强的降压效果<|>6\")  \n##  \n(\"relationship\"<|>沙库巴曲缬沙坦<|>沙库巴曲阿利沙坦<|>两者均为ARNI类药物，但沙库巴曲阿利沙坦是新型药物，具有更显著的降压效果<|>5\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558624, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 385, "prompt_tokens": 2525, "total_tokens": 2910, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 733}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ��进入人体不能同时被吸  收 ,使两药的吸收与消除速率相近 ,保障了药效发挥的  同步性[273-274] 。\n　　在亚洲和全球的多项研究中 ,与 ARB相比 ,沙库巴  曲缬沙坦可额外使诊室收缩压降低 5~ 7 mmHg[275]  ;  使 24h动态收缩压和舒张压分别进一步降低 3.7 和  1.7 mmHg[276] 。对于 CCB治疗后不达标的高血压患  者 , 与 CCB单 药 相 比 , ARNI+CCB联 合 治 疗 可 使  24h动态收缩压和舒张压分别进一步降低 13.1 和  7.7 mmHg[277] 。 国内一项多中心非对照研究证实 ,沙  库巴曲缬沙坦替换 RAS抑制剂能显著降低无严重肝、 肾功能损害的难治性高血压患者的诊室血压和 24 h 动态血压 , 提高血压达标率[278] 。该药也有助于控制  HFpEF患者的难治性高血压[至少使用了包括盐皮  质激素受体拮抗剂(mineralocorticoid receptorantag- onist,MRA) 的 4种降压药][279] 。沙库巴曲缬沙坦在  部分特殊人群中有一定的降压优势 ,包括高血压合并  心力衰竭、LVH、肾脏疾病、老年及难治性高血压[280] 。\n　　　沙 库 巴 曲 阿 利 沙 坦 的 Ⅲ 期 临 床 试 验 结 果 显  示[272]  ,在轻中度高血压患者中 , 与奥美沙坦相比 , 沙  库巴曲阿利沙坦 240mg和 480mg在诊室血压 ,24h、 白天和夜间的收缩压/舒张压的降幅均更大(480 mg,\n\n\nP≤0.001) ,且有明显的剂量依赖性 , 52周长期应用 数据显示其耐受性良好。\n　　　ARNI在联合治疗中可与 CCB、β受体阻滞剂、利 尿剂联用 ,但不能与 ACEI、ARB(相同成分的 ARB除 外) 、阿利吉仑联用[280] 。如果从 ACEI转换成 ARNI, 必须 在 停 止 ACEI治 疗 至 少 36 h(相 当 于 大 多 数 ACEI的 2~3个消除半衰期) 之后才能开始应用 , 以 降低发生潜在的血管性水肿的风险 , 同时又不易导致 心力衰竭恶化或血压明显波动。\n　　　ARNI可导致血管性水肿、低血压、肾功能损害、 高 钾 血 症 。 重 度 肾 功 能 损 害 [ eGFR< 30 mL/ (min · 1.73 m2)] 、肾动脉狭窄及中度肝功能损害者  应慎用 ARNI,妊娠者禁用[280] 。\n　　　(7) α受体阻滞剂 :虽不作为常用的降压药使用 ,  但 α受体阻滞剂仍可在多种临床情况下发挥重要的治  疗作用 。该类药物适用于高血压合并良性前列腺增  生、原发性震颤、血糖或血脂异常、难\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_4de7ad54ba9c9a2dc8d6a6d4b2605e9f5dfd6225739f651bad88688a8dfc675f_v2"}